
Alcon Science
@SeeAlconScience
Followers
1K
Following
12
Media
343
Statuses
439
Learn about the science behind innovations from Alcon. This channel is intended for US Based HCPs only. See our community guidelines: https://t.co/OhMFHMoUKa
Joined March 2023
From promising new #DryEye and #Glaucoma medications to anti-inflammatory and allergy treatments, catch up on pharmaceutical innovations from #Alcon here: #AlconScience #MedicalAffairs #Ophthalmology #Optometry
1
2
5
Thanks to advancements in phacoemulsification technology, surgeons can preset intraocular pressure (IOP) settings to be maintained throughout #CataractSurgery. This video by #Alcon summarizes a study evaluating the impact of operating at physiologic vs high IOP.
0
1
3
This clip summarizes results from a study of the impact of maintaining a high intraocular pressure (IOP) vs a near-physiologic IOP during #CataractSurgery. See the full video from #Alcon Global Medical Affairs here: #Ophthalmology #AlconInnovation
0
2
3
#DryEyeDisease (DED) impacts approximately 38 million Americans. This figure underscores the substantial unmet need and the importance of innovative therapies to better manage this widespread condition. Visit to learn more. #AlconScience #MedicalAffairs
1
1
4
#Glaucoma and ocular hypertension treatment study: Watch this video from #Alcon Global Medical Affairs to see how intraocular pressure (IOP)-lowering Rho-kinase inhibitor netarsudil performs under real-world treatment conditions: #Ophthalmology
0
1
3
In this clinical trial, 27 subjects underwent bilateral #CataractSurgery using the Centurion® Vision System with ACTIVE SENTRY®, maintaining one eye at ≤28 mmHg intraocular pressure (IOP) and the other at ≥55-60 mmHg. See the results below. #AlconInnovation #Ophthalmology
0
1
4
How does maintaining a higher intraocular pressure (IOP) vs a near-physiologic IOP during #CataractSurgery affect surgical efficiency and ocular tissue? Find out in this study summary video from #Alcon Global Medical Affairs: . #Ophthalmology
0
1
4
As part of Alcon’s commitment to delivering innovative products to patients worldwide, we support independent clinical research via our Investigator-Initiated Trial (IIT) Program. Explore our areas of interest here: . #AlconScience #MedicalAffairs
0
1
3
Click through to watch the latest clinical research summary highlight Dr. Lillie Mosaddegh’s recent study on the visual outcomes and patient satisfaction with a trifocal IOL with advanced hydrophobic acrylic biomaterial. See more: #CataractSurgery #Alcon
0
1
2
Dr. Lillie Mosaddegh highlights corrected and uncorrected visual acuities, refractive outcomes and patient-reported satisfaction after bilateral implantation of Clareon® PanOptix® intraocular lenses. See the full video: #CataractSurgery #AlconInnovation
0
1
3
In recent phase 3 clinical trials, acoltremon 0.003% ophthalmic solution demonstrated effectiveness in increasing tear production. For more information about acoltremon ophthalmic solution 0.003%, visit #AlconScience #Innovation
0
2
4
Access trusted science at your fingertips. The #AlconScience Eyetube Portal features educational videos and clinical insights from top researchers and clinicians. #Eyetube . Visit Alcon Science on Eyetube:
0
1
3
Are cataract patients with presbyopia satisfied with Clareon® PanOptix® trifocal intraocular lenses (IOLs) 3 months after cataract surgery? Dr. Marius Scheepers recently conducted a study to find out. See the full video here: #Ophthalmology #Alcon
0
1
2